Oncological Engineering:
A new concept in the treatment of bone metastases

Cancer prevalence in the UK is set to rise from 2 million in 2015 to 3.2 million by 2030. Metastases are the primary cause of mortality for many cancers.

Annually, 55,000 cases of bone cancer are diagnosed in the UK and of these 2/3rd patients will develop into metastatic bone disease

In the spine metastates can destroy bone in the vertebrae, weakening it and can cause significant spinal cord injury leading to paralysis.

A more patient-friendly approach is realised in OncoEng in which we predict which vertebrae with tumours are likely to fail in the future enabling informed decision on care.

Advanced computational modelling and imaging will be used to look at the growth of the tumour so that predictions of the strength of the vertebrae can be calculated a different points in time.

Custom implants requiring only key-hole surgery will be developed to support the weakened bone in order to prevent fracture, optimised to reduce impingement to the patients life through a lengthy recuperation period or additional pain.

Latest News

Research Challenge 2: Modelling Spinal Biomechanics

Research challenge 2 (RC2) is centred around the need for the development of an advanced spinal rigid-body modelling technique. This is required to determine the expected vertebral loads and motion across a range of daily…

MetUp UK: Darker Side of Pink Exhibition

Today I visited the #DarkerPink exhibition at the Danum Gallery and Museum in Doncaster. The presence of dark pink figures, listening to their stories as I stood in front of them, really brought home the…

OncoEng Kickoff Meeting

The 10th of June marked the beginning of OncoEng, in which academics, early-stage researchers, patient advocates, and representatives from invested companies met in Weetwood Hall, Leeds for the kick-off meeting. The day began with a…